REG - Craneware plc - Board Appointment

CranewareAnnouncement

27/04/2022 13:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220427:nRSa5365Ja&default-theme=true

RNS Number : 5365J  Craneware plc  27 April 2022

Craneware plc

("Craneware" or the "Company" or the "Group")

Board Appointment

 

27 April 2022 - Craneware (AIM: CRW.L), the market leader in Value Cycle
solutions for the US healthcare market, is pleased to announce the appointment
of Isabel ("Issy") Urquhart, Chief People Officer, to the Board of Directors,
with immediate effect.

 

Having joined Craneware in 2015, Issy is a valued member of the Operation's
Board of the Company and was instrumental in the integration of the Sentry
team following the acquisition last year. In her role, Issy leads on the
development and implementation of HR, organisation design and development and
change management strategies. Previous roles include HR Director EMEA at
CommScope, a Fortune 500 organisation employing 30,000 employees worldwide and
Vice President of HR at Wolfson Microelectronics plc, a FTSE 350 Company. Issy
is also prominent in the Scottish charitable and not for profit spheres, in
her roles as Vice-Chair of the Edinburgh Business Beats Cancer Board and
member of the Scottish and North American Business Council.

 

Will Whitehorn, Chair of Craneware plc, commented,

 

"Issy has been central in the successful integration of the Sentry team into
the Craneware Group and we are delighted to have a leader with her skillset
join the Board of Directors. Issy's appointment reflects the importance we
place on creating the right environment for our people to thrive and the
increased scale of the Craneware Group."

 

Director Appointment Information

 

Issy Urquhart (née Houghton), aged 54, has an interest in 6,577 ordinary
shares of 1p each in the Company ("Ordinary Shares"), representing 0.02% of
the issued share capital, 8,257 share options to acquire Ordinary Shares and
conditional awards of 25,686 Ordinary Shares under the Company's Long Term
Incentive Plan.

 

There are no further disclosures required in accordance with AIM Rule 17 and
Schedule Two paragraph (g) of the AIM Rules for Companies.

 

For further information, please contact:

 Craneware plc                                               +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma (Financial PR)                                         +44 (0)20 3405 0205
 Caroline Forde, Hilary Buchanan, Joe Pederzolli             craneware@almapr.co.uk

 Peel Hunt (NOMAD and Joint Broker)                          +44 (0)20 7418 8900
 Dan Webster, Andrew Clark

 Investec Bank PLC (Joint Broker)                            +44 (0)20 7597 5970
 Patrick Robb, Henry Reast, Sebastian Lawrence
 ( )
 Berenberg (Joint Broker)                                    +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

 

About Craneware

 

We at the Craneware Group of companies, including our latest additions Sentry
Data Systems and Agilum Healthcare Intelligence, passionately believe we can
impact healthcare profoundly by delivering the insights healthcare
organizations need to also transform the business of healthcare. Our shared
vision is to be the operational and financial partner for U.S. healthcare
providers.

 

Our combined suite of applications and industry-leading team of experts help
our customers contextualize operational, financial, and clinical data,
providing insights that clearly demonstrate what great looks like. These value
cycle insights deliver revenue integrity and 340B compliance, as well as
margin and operational intelligence - something no other single partner can
provide.

 

Together, approximately 40% of registered U.S. hospitals are now our
customers, including more than 2000 U.S hospitals and health systems and
almost 10,000 clinics and retail pharmacies. Our customers are operating with
a financial impact of nearly half a trillion dollars. We have data sets from
customers covering more than 150 million unique patients encounters.

Learn more at craneware.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAIRMLTMTJTMBT